866-997-4948(US-Canada Toll Free)

United States Cyclophosphamide Market Report 2017

Published By :

QYResearch

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 101 Pages

In this report, the United States Cyclophosphamide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Cyclophosphamide in these regions, from 2012 to 2022 (forecast).

United States Cyclophosphamide market competition by top manufacturers/players, with Cyclophosphamide sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Sanofi
CSC PHARMACEUTICALS INTERNATIONAL
LGM Pharma
Pfizer
Merck
Allergan
The Medicines Company
Theravance Biopharma
Basilea Pharmaceutica

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Cyclophosphamide Powder
Cyclophosphamide Injection
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cyclophosphamide for each application, including
Malignant Lymphoma
Multiple Myeloma
Leukemia
Breast Cancer
Bronchial Carcinoma
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Cyclophosphamide Market Report 2017
1 Cyclophosphamide Overview
1.1 Product Overview and Scope of Cyclophosphamide
1.2 Classification of Cyclophosphamide by Product Category
1.2.1 United States Cyclophosphamide Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Cyclophosphamide Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Cyclophosphamide Powder
1.2.4 Cyclophosphamide Injection
1.3 United States Cyclophosphamide Market by Application/End Users
1.3.1 United States Cyclophosphamide Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Malignant Lymphoma
1.3.3 Multiple Myeloma
1.3.4 Leukemia
1.3.5 Breast Cancer
1.3.6 Bronchial Carcinoma
1.3.7 Other
1.4 United States Cyclophosphamide Market by Region
1.4.1 United States Cyclophosphamide Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Cyclophosphamide Status and Prospect (2012-2022)
1.4.3 Southwest Cyclophosphamide Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Cyclophosphamide Status and Prospect (2012-2022)
1.4.5 New England Cyclophosphamide Status and Prospect (2012-2022)
1.4.6 The South Cyclophosphamide Status and Prospect (2012-2022)
1.4.7 The Midwest Cyclophosphamide Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cyclophosphamide (2012-2022)
1.5.1 United States Cyclophosphamide Sales and Growth Rate (2012-2022)
1.5.2 United States Cyclophosphamide Revenue and Growth Rate (2012-2022)

2 United States Cyclophosphamide Market Competition by Players/Suppliers
2.1 United States Cyclophosphamide Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cyclophosphamide Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cyclophosphamide Average Price by Players/Suppliers (2012-2017)
2.4 United States Cyclophosphamide Market Competitive Situation and Trends
2.4.1 United States Cyclophosphamide Market Concentration Rate
2.4.2 United States Cyclophosphamide Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cyclophosphamide Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cyclophosphamide Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Cyclophosphamide Sales and Market Share by Region (2012-2017)
3.2 United States Cyclophosphamide Revenue and Market Share by Region (2012-2017)
3.3 United States Cyclophosphamide Price by Region (2012-2017)

4 United States Cyclophosphamide Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Cyclophosphamide Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cyclophosphamide Revenue and Market Share by Type (2012-2017)
4.3 United States Cyclophosphamide Price by Type (2012-2017)
4.4 United States Cyclophosphamide Sales Growth Rate by Type (2012-2017)

5 United States Cyclophosphamide Sales (Volume) by Application (2012-2017)
5.1 United States Cyclophosphamide Sales and Market Share by Application (2012-2017)
5.2 United States Cyclophosphamide Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Cyclophosphamide Players/Suppliers Profiles and Sales Data
6.1 Sanofi
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cyclophosphamide Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sanofi Cyclophosphamide Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 CSC PHARMACEUTICALS INTERNATIONAL
6.2.2 Cyclophosphamide Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 LGM Pharma
6.3.2 Cyclophosphamide Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 LGM Pharma Cyclophosphamide Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Cyclophosphamide Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Cyclophosphamide Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck
6.5.2 Cyclophosphamide Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck Cyclophosphamide Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Allergan
6.6.2 Cyclophosphamide Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Allergan Cyclophosphamide Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 The Medicines Company
6.7.2 Cyclophosphamide Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 The Medicines Company Cyclophosphamide Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Theravance Biopharma
6.8.2 Cyclophosphamide Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Theravance Biopharma Cyclophosphamide Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Basilea Pharmaceutica
6.9.2 Cyclophosphamide Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Basilea Pharmaceutica Cyclophosphamide Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview

7 Cyclophosphamide Manufacturing Cost Analysis
7.1 Cyclophosphamide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cyclophosphamide

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cyclophosphamide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cyclophosphamide Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Cyclophosphamide Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Cyclophosphamide Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cyclophosphamide Sales Volume Forecast by Type (2017-2022)
11.3 United States Cyclophosphamide Sales Volume Forecast by Application (2017-2022)
11.4 United States Cyclophosphamide Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Cyclophosphamide
Figure United States Cyclophosphamide Market Size (MT) by Type (2012-2022)
Figure United States Cyclophosphamide Sales Volume Market Share by Type (Product Category) in 2016
Figure Cyclophosphamide Powder Product Picture
Figure Cyclophosphamide Injection Product Picture
Figure United States Cyclophosphamide Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Cyclophosphamide by Application in 2016
Figure Malignant Lymphoma Examples
Table Key Downstream Customer in Malignant Lymphoma
Figure Multiple Myeloma Examples
Table Key Downstream Customer in Multiple Myeloma
Figure Leukemia Examples
Table Key Downstream Customer in Leukemia
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Bronchial Carcinoma Examples
Table Key Downstream Customer in Bronchial Carcinoma
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Cyclophosphamide Market Size (Million USD) by Region (2012-2022)
Figure The West Cyclophosphamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cyclophosphamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cyclophosphamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cyclophosphamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cyclophosphamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cyclophosphamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cyclophosphamide Sales (MT) and Growth Rate (2012-2022)
Figure United States Cyclophosphamide Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cyclophosphamide Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Cyclophosphamide Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Cyclophosphamide Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cyclophosphamide Sales Share by Players/Suppliers
Figure 2017 United States Cyclophosphamide Sales Share by Players/Suppliers
Figure United States Cyclophosphamide Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cyclophosphamide Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cyclophosphamide Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cyclophosphamide Revenue Share by Players/Suppliers
Figure 2017 United States Cyclophosphamide Revenue Share by Players/Suppliers
Table United States Market Cyclophosphamide Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Cyclophosphamide Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Cyclophosphamide Market Share of Top 3 Players/Suppliers
Figure United States Cyclophosphamide Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cyclophosphamide Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cyclophosphamide Product Category
Table United States Cyclophosphamide Sales (MT) by Region (2012-2017)
Table United States Cyclophosphamide Sales Share by Region (2012-2017)
Figure United States Cyclophosphamide Sales Share by Region (2012-2017)
Figure United States Cyclophosphamide Sales Market Share by Region in 2016
Table United States Cyclophosphamide Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cyclophosphamide Revenue Share by Region (2012-2017)
Figure United States Cyclophosphamide Revenue Market Share by Region (2012-2017)
Figure United States Cyclophosphamide Revenue Market Share by Region in 2016
Table United States Cyclophosphamide Price (USD/Kg) by Region (2012-2017)
Table United States Cyclophosphamide Sales (MT) by Type (2012-2017)
Table United States Cyclophosphamide Sales Share by Type (2012-2017)
Figure United States Cyclophosphamide Sales Share by Type (2012-2017)
Figure United States Cyclophosphamide Sales Market Share by Type in 2016
Table United States Cyclophosphamide Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cyclophosphamide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cyclophosphamide by Type (2012-2017)
Figure Revenue Market Share of Cyclophosphamide by Type in 2016
Table United States Cyclophosphamide Price (USD/Kg) by Types (2012-2017)
Figure United States Cyclophosphamide Sales Growth Rate by Type (2012-2017)
Table United States Cyclophosphamide Sales (MT) by Application (2012-2017)
Table United States Cyclophosphamide Sales Market Share by Application (2012-2017)
Figure United States Cyclophosphamide Sales Market Share by Application (2012-2017)
Figure United States Cyclophosphamide Sales Market Share by Application in 2016
Table United States Cyclophosphamide Sales Growth Rate by Application (2012-2017)
Figure United States Cyclophosphamide Sales Growth Rate by Application (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Cyclophosphamide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Cyclophosphamide Sales Growth Rate (2012-2017)
Figure Sanofi Cyclophosphamide Sales Market Share in United States (2012-2017)
Figure Sanofi Cyclophosphamide Revenue Market Share in United States (2012-2017)
Table CSC PHARMACEUTICALS INTERNATIONAL Basic Information List
Table CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Sales Growth Rate (2012-2017)
Figure CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Sales Market Share in United States (2012-2017)
Figure CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Revenue Market Share in United States (2012-2017)
Table LGM Pharma Basic Information List
Table LGM Pharma Cyclophosphamide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure LGM Pharma Cyclophosphamide Sales Growth Rate (2012-2017)
Figure LGM Pharma Cyclophosphamide Sales Market Share in United States (2012-2017)
Figure LGM Pharma Cyclophosphamide Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Cyclophosphamide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Cyclophosphamide Sales Growth Rate (2012-2017)
Figure Pfizer Cyclophosphamide Sales Market Share in United States (2012-2017)
Figure Pfizer Cyclophosphamide Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Cyclophosphamide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck Cyclophosphamide Sales Growth Rate (2012-2017)
Figure Merck Cyclophosphamide Sales Market Share in United States (2012-2017)
Figure Merck Cyclophosphamide Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Cyclophosphamide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Allergan Cyclophosphamide Sales Growth Rate (2012-2017)
Figure Allergan Cyclophosphamide Sales Market Share in United States (2012-2017)
Figure Allergan Cyclophosphamide Revenue Market Share in United States (2012-2017)
Table The Medicines Company Basic Information List
Table The Medicines Company Cyclophosphamide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure The Medicines Company Cyclophosphamide Sales Growth Rate (2012-2017)
Figure The Medicines Company Cyclophosphamide Sales Market Share in United States (2012-2017)
Figure The Medicines Company Cyclophosphamide Revenue Market Share in United States (2012-2017)
Table Theravance Biopharma Basic Information List
Table Theravance Biopharma Cyclophosphamide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Theravance Biopharma Cyclophosphamide Sales Growth Rate (2012-2017)
Figure Theravance Biopharma Cyclophosphamide Sales Market Share in United States (2012-2017)
Figure Theravance Biopharma Cyclophosphamide Revenue Market Share in United States (2012-2017)
Table Basilea Pharmaceutica Basic Information List
Table Basilea Pharmaceutica Cyclophosphamide Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Basilea Pharmaceutica Cyclophosphamide Sales Growth Rate (2012-2017)
Figure Basilea Pharmaceutica Cyclophosphamide Sales Market Share in United States (2012-2017)
Figure Basilea Pharmaceutica Cyclophosphamide Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cyclophosphamide
Figure Manufacturing Process Analysis of Cyclophosphamide
Figure Cyclophosphamide Industrial Chain Analysis
Table Raw Materials Sources of Cyclophosphamide Major Players/Suppliers in 2016
Table Major Buyers of Cyclophosphamide
Table Distributors/Traders List
Figure United States Cyclophosphamide Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Cyclophosphamide Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cyclophosphamide Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Cyclophosphamide Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Cyclophosphamide Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Cyclophosphamide Sales Volume (MT) Forecast by Type in 2022
Table United States Cyclophosphamide Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Cyclophosphamide Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Cyclophosphamide Sales Volume (MT) Forecast by Application in 2022
Table United States Cyclophosphamide Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Cyclophosphamide Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cyclophosphamide Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cyclophosphamide Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *